Research Articles
PROTACs and Breast Cancer: Degrading the Engine of Tumor Growth
Explore the revolutionary PROTAC technology targeting CDKs for breast cancer treatment - from inhibition to complete protein degradation.
Nature's Hidden Key: How a Plant Compound Could Revolutionize Breast Cancer Treatment
Discover how α-Cyperone, a compound from Cyperus rotundus, targets TRIM24 protein to combat breast cancer development and chemotherapy resistance.
MDM2: The P53-Independent Driver of Breast Cancer's Deadly Spread
Groundbreaking research reveals MDM2's independent role in driving breast cancer metastasis through pathways separate from p53, opening new treatment possibilities.
The Cellular Tug-of-War: How a Cancer Gene Decides the Fate of Cellular Power Plants
Discover how Akt2 regulates mitophagy in breast cancer cells and its implications for cancer therapy.
SNIPER(ER): The Molecular Assassins Revolutionizing Breast Cancer Treatment
Explore how SNIPER(ER) molecules target and degrade ERα proteins in breast cancer treatment through innovative protein degradation technology.
The RAP80-ERα Connection: How a Molecular Handler Fine-Tunes a Cancer Catalyst
Discover how RAP80 selectively interacts with estrogen receptor alpha to fine-tune breast cancer biology and DNA repair mechanisms.
The Double Life of Ribosomal Proteins: How a Cellular Modification Fuels Cancer Survival
Discover how neddylation of ribosomal proteins RPS27 and RPS27L promotes cancer cell survival, offering new therapeutic targets for breast cancer treatment.
The Guardian's Betrayal: How BARD1 is Revolutionizing the Fight Against Breast Cancer
Discover how BARD1 gene research is transforming breast cancer screening, prevention, and treatment for predisposed women.
CISD1: A Breast Cancer Prognostic Biomarker Associated with Diabetes Mellitus
Discover how the CISD1 protein bridges breast cancer and diabetes, serving as a crucial prognostic biomarker and potential therapeutic target.
Disarming a Cancer's Bodyguard: How a Tiny Protein Could Revolutionize Breast Cancer Treatment
Discover how knocking down the UbcH10 protein can re-sensitize drug-resistant breast cancer cells to chemotherapy drugs Epirubicin and Docetaxel.